Citing lack of benefit, NIH halts trial of hydroxychloroquine for COVID-19
(HealthDay)—The U.S. National Institutes of Heath announced Saturday that it was stopping a clinical trial of hydroxychloroquine, a drug long
Read more(HealthDay)—The U.S. National Institutes of Heath announced Saturday that it was stopping a clinical trial of hydroxychloroquine, a drug long
Read more